232 related articles for article (PubMed ID: 31589807)
1. The Neurocognitive Assessment in the Metabolic and Aging Cohort (NAMACO) study: baseline participant profile.
Métral M; Darling K; Locatelli I; Nadin I; Santos G; Brugger P; Kovari H; Cusini A; Gutbrod K; Tarr PE; Calmy A; Lecompte TD; Assal F; Monsch A; Kunze U; Stoeckle M; Schwind M; Schmid P; Pignatti R; Di Benedetto C; Du Pasquier R; Cavassini M; ;
HIV Med; 2020 Jan; 21(1):30-42. PubMed ID: 31589807
[TBL] [Abstract][Full Text] [Related]
2. Alcohol consumption and neurocognitive deficits in people with well-treated HIV in Switzerland.
Darling KEA; Locatelli I; Benghalem N; Nadin I; Calmy A; Gutbrod K; Hauser C; Brugger P; Hasse B; Kovari H; Kunze U; Stoeckle M; Fux C; Rossi S; Di Benedetto C; Früh S; Schmid P; Tarr PE; Daeppen JB; Du Pasquier R; Cavassini M;
PLoS One; 2021; 16(3):e0246579. PubMed ID: 33651794
[TBL] [Abstract][Full Text] [Related]
3. Neurocognitive course at 2-year follow-up in a Swiss cohort of people with well-treated HIV.
Damas J; Ledergerber B; Nadin I; Tarr PE; Stoeckle M; Kunze U; Hauser C; Gutbrod K; Calmy A; Assal F; Schmid P; Hundsberger T; Di Benedetto C; Rossi S; Hasse B; Schlosser L; Du Pasquier R; Darling KEA; Cavassini M;
AIDS; 2021 Dec; 35(15):2469-2480. PubMed ID: 34411034
[TBL] [Abstract][Full Text] [Related]
4. The association between depressive symptoms and neurocognitive impairment in people with well-treated HIV in Switzerland.
Santos G; Locatelli I; Métral M; Berney A; Nadin I; Calmy A; Tarr P; Gutbrod K; Hauser C; Brugger P; Kovari H; Kunze U; Stoeckle M; Früh S; Schmid P; Rossi S; Di Benedetto C; Du Pasquier R; Darling K; Cavassini M;
Int J STD AIDS; 2021 Jul; 32(8):729-739. PubMed ID: 33629882
[TBL] [Abstract][Full Text] [Related]
5. How helpful are the European AIDS Clinical Society cognitive screening questions in predicting cognitive impairment in an aging, well-treated HIV-positive population?
Metral M; Nadin I; Locatelli I; Tarr PE; Calmy A; Kovari H; Brugger P; Cusini A; Gutbrod K; Schmid P; Schwind M; Kunze U; Di Benedetto C; Pignatti R; Du Pasquier R; Darling K; Cavassini M;
HIV Med; 2020 May; 21(5):342-348. PubMed ID: 31883203
[TBL] [Abstract][Full Text] [Related]
6. Neurocognitive Impairment in Well-Controlled HIV-Infected Patients: A Cross-Sectional Study.
Portilla I; Reus S; León R; van-der Hofstadt C; Sánchez J; López N; Boix V; Merino E; Portilla J
AIDS Res Hum Retroviruses; 2019 Jul; 35(7):634-641. PubMed ID: 30880401
[TBL] [Abstract][Full Text] [Related]
7. Cross-Sectional and Cumulative Longitudinal Central Nervous System Penetration Effectiveness Scores Are Not Associated With Neurocognitive Impairment in a Well Treated Aging Human Immunodeficiency Virus-Positive Population in Switzerland.
Santos GMA; Locatelli I; Métral M; Calmy A; Lecompte TD; Nadin I; Hauser C; Cusini A; Hasse B; Kovari H; Tarr P; Stoeckle M; Fux C; Di Benedetto C; Schmid P; Darling KEA; Du Pasquier R; Cavassini M;
Open Forum Infect Dis; 2019 Jul; 6(7):ofz277. PubMed ID: 31304188
[TBL] [Abstract][Full Text] [Related]
8. Cerebrospinal Fluid HIV-1 Escape in Patients With Neurocognitive Symptoms: Pooled Data From a Neuro-HIV Platform and the NAMACO Study.
Filippidis P; Damas J; Viala B; Assal F; Nawej Tshikung O; Tarr P; Derfuss T; Oberholzer M; Jelcic I; Hundsberger T; Sacco L; Cavassini M; Du Pasquier R; Darling KEA;
J Acquir Immune Defic Syndr; 2023 Jul; 93(3):219-228. PubMed ID: 36927958
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of HIV-associated neurocognitive disorder (HAND) in Turkey and assessment of Addenbrooke's Cognitive Examination Revised (ACE-R) test as a screening tool.
Korten V; Ay U; Harı E; Tigen Tükenmez E; Gencer S; Akça Kalem S; Demirtaş Tatlıdede A; Gürvit İH
HIV Med; 2021 Jan; 22(1):60-66. PubMed ID: 32964651
[TBL] [Abstract][Full Text] [Related]
10. Depression and diagnosis of neurocognitive impairment in HIV-positive patients.
Pinheiro CA; Souza LD; Motta JV; Kelbert EF; Souza MS; Martins CS; Coelho FM; Pinheiro KA; Pinheiro RT
Braz J Med Biol Res; 2016 Sep; 49(10):e5344. PubMed ID: 27626305
[TBL] [Abstract][Full Text] [Related]
11. Neurocognitive Impairment in the Combined Antiretroviral Therapy Era in a Romanian Cohort of Young Adults with Chronic HIV Infection.
Temereanca A; Ene L; Rosca A; Diaconu CC; Luca A; Burlacu R; Radoi R; Bulacu-Talnariu A; Marcotte TD; Achim CL; Ruta S
AIDS Res Hum Retroviruses; 2020 May; 36(5):367-372. PubMed ID: 31476875
[TBL] [Abstract][Full Text] [Related]
12. Vitamin D deficiency is associated with neurocognitive impairment in HIV-infected subjects.
Vergori A; Pinnetti C; Lorenzini P; Brita A; Libertone R; Mastrorosa I; Cicalini S; Antinori A; Ammassari A
Infection; 2019 Dec; 47(6):929-935. PubMed ID: 31183805
[TBL] [Abstract][Full Text] [Related]
13. Prevalence and 1-year incidence of HIV-associated neurocognitive disorder (HAND) in adults aged ≥50 years attending standard HIV clinical care in Kilimanjaro, Tanzania.
Flatt A; Gentry T; Kellett-Wright J; Eaton P; Joseph M; Urasa S; Howlett W; Dekker M; Kisoli A; Rogathe J; Henderson L; Lewis T; Thornton J; McCartney J; Yarwood V; Irwin C; Mukaetova-Ladinska EB; Akinyemi R; Gray WK; Walker RW; Dotchin CL; Quaker AS; Makupa PC; Paddick SM
Int Psychogeriatr; 2023 Jul; 35(7):339-350. PubMed ID: 33757616
[TBL] [Abstract][Full Text] [Related]
14. Increased Prevalence of Neurocognitive Impairment in Aging People Living With Human Immunodeficiency Virus: The ANRS EP58 HAND 55-70 Study.
Makinson A; Dubois J; Eymard-Duvernay S; Leclercq P; Zaegel-Faucher O; Bernard L; Vassallo M; Barbuat C; Gény C; Thouvenot E; Costagliola D; Ozguler A; Zins M; Simony M; Reynes J; Berr C
Clin Infect Dis; 2020 Jun; 70(12):2641-2648. PubMed ID: 31755936
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of non-confounded HIV-associated neurocognitive impairment in the context of plasma HIV RNA suppression.
Cysique LA; Brew BJ
J Neurovirol; 2011 Apr; 17(2):176-83. PubMed ID: 21416169
[TBL] [Abstract][Full Text] [Related]
16. Neurocognitive impairment in treatment-experienced adults living with HIV attending primary care clinics in Zimbabwe.
Nyamayaro P; Gouse H; Hakim J; Robbins RN; Chibanda D
BMC Infect Dis; 2020 May; 20(1):383. PubMed ID: 32471350
[TBL] [Abstract][Full Text] [Related]
17. Correlates of the HIV-associated neurocognitive disorders among adults living with HIV in Dodoma region, central Tanzania: A cross-sectional study.
Nyundo AA
PLoS One; 2023; 18(5):e0285761. PubMed ID: 37228133
[TBL] [Abstract][Full Text] [Related]
18. Metabolic Risk Factors as Differential Predictors of Profiles of Neurocognitive Impairment Among Older HIV+ and HIV- Adults: An Observational Study.
Pasipanodya EC; Montoya JL; Campbell LM; Hussain MA; Saloner R; Paolillo EM; Jeste DV; Letendre SL; McCutchan JA; Heaton RK; Moore DJ
Arch Clin Neuropsychol; 2021 Feb; 36(2):151-164. PubMed ID: 31696212
[TBL] [Abstract][Full Text] [Related]
19. Human Immunodeficiency Virus-associated Neurocognitive Impairment in Diverse Resource-limited Settings.
Robertson KR; Jiang H; Kumwenda J; Supparatpinyo K; Marra CM; Berzins B; Hakim J; Sacktor N; Campbell TB; Schouten J; Mollan K; Tripathy S; Kumarasamy N; La Rosa A; Santos B; Silva MT; Kanyama C; Firhnhaber C; Murphy R; Hall C; Marcus C; Naini L; Masih R; Hosseinipour MC; Mngqibisa R; Badal-Faesen S; Yosief S; Vecchio A; Nair A;
Clin Infect Dis; 2019 May; 68(10):1733-1738. PubMed ID: 30219843
[TBL] [Abstract][Full Text] [Related]
20. HIV-Associated Neurocognitive Disorders: The First Longitudinal Follow-Up of a cART-Treated Cohort of Older People in Sub-Saharan Africa.
Spooner R; Ranasinghe S; Urasa S; Yoseph M; Koipapi S; Mukaetova-Ladinska EB; Lewis T; Howlett W; Dekker M; Kisoli A; Gray WK; Walker RW; Dotchin CL; Kalaria R; Lwezuala B; Makupa PC; Akinyemi R; Paddick SM
J Acquir Immune Defic Syndr; 2022 Jun; 90(2):214-222. PubMed ID: 35125473
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
